Live Breaking News & Updates on Fellow Eye

Stay updated with breaking news from Fellow eye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Judith Mcgarry , Beth Keshishian , Greg Kunst , Prix Galien , Elizabeth Yeu , Michael Goldstein , Michele Gray , Devices Agency , American Society Of Cataract , Company Escal , Omni Boston Hotel , Boston Convention Exhibition Center , Japan Pharmaceuticals , Refractive Surgery , Annual Meeting , Endothelial Cell Therapy , Corneal Endothelial Disease , Chief Executive Officer , Aurion Biotech , Corneal Edema Receiving Endothelial Cells , One Eye , Fellow Eye , Exhibition Center , Chief Medical Officer ,

REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Steve Pakola , Dane Leone , Andreas Argyrides , Lisa Walter , Mani Foroohar , Patrick Christmas , Alec Stranahan , Caroline Palomeque , Brian Skorney , Ellie Merle , Gena Wang , University Of Pennsylvania , Morgan Stanley , American Academy Of Ophthalmology Meeting , Regenxbio Inc , American Academy Of Ophthalmology , World Muscle Society Congress , Society For The Study , Exchange Commission , World Muscle Society , Rockville Manufacturing Innovation Center , Call Transcript August , Chief Legal , Ken Mills , Chief Medical Officer ,

REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights

Continued progress on 5x 25 strategy to advance five AAV Therapeutics from REGENXBIO s internal pipeline and licensed programs into pivotal-stage or. ....

United States , Chris Brinzey , Rocket Pharmaceuticals , American Academy Of Ophthalmology , Technology Platform , Technology Platform Licensees , Development Expenses , American Society Of Retina Specialists , World Muscle Society Congress , Drug Agency , Exchange Commission , Ultragenyx Pharmaceutical Inc , Securities Exchange , World Muscle Society , Manufacturing Innovation Center , European Medicines Agency , Chief Executive Officer , Long Term Follow Up , Fellow Eye , Innovation Center , American Society , Retina Specialists , American Academy , Hawaiian Eye , Duchenne Muscular Dystrophy , Biologics License Application ,